Literature DB >> 21908947

The characteristics of food intake in patients with type II citrullinemia.

Mio Nakamura1, Masahide Yazaki, Yumiko Kobayashi, Kazuhiro Fukushima, Shu-ichi Ikeda, Keiko Kobayashi, Takeyori Saheki, Yutaka Nakaya.   

Abstract

Some patients with citrin deficiency caused by SLC25A13 gene mutations develop adult-onset type II citrullinemia (CTLN2) with hepatic encephalopathy. A recent nutritional survey of 18 citrin-deficient subjects (age 1-33 y) confirmed a marked decrease in carbohydrate intake compared to an age-matched general Japanese population. However, a quantitative understanding of food intake in CTLN2 patients remains unclear, although qualitative dietary information has been reported. In order to elucidate the characteristics of daily nutrition of CTLN2 patients, the food intake of 5 male patients (age 39-52 y) was investigated in detail by the Food Frequency Questionnaire. In the present survey, the mean energy ratio of protein : fat : carbohydrate (PFC ratio) of the 5 patients was 19±3% : 44±5% : 37±4%, which was almost identical to previously reported data in younger citrin-deficient subjects (19±2% : 44±5% : 37±7%). Cereal intake was especially low in all CTLN2 patients at 309±33 g/d (56% of control), compared to that in an age-matched general Japanese population (553±197 g/d). Additionally, CTLN2 patients preferred high fat and protein foods. Commonly, fat intake declines with age in the general Japanese population, but this tendency was not observed in the 5 CTLN2 patients. The present results suggest that intakes of low-carbohydrate, high-protein and high-fat food was characteristic the 5 CTLN2 patients surveyed, as has been previously reported in younger citrin-deficient subjects, and that the PFC ratio may not be influenced by age or CTLN2-onset.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21908947     DOI: 10.3177/jnsv.57.239

Source DB:  PubMed          Journal:  J Nutr Sci Vitaminol (Tokyo)        ISSN: 0301-4800            Impact factor:   2.000


  6 in total

1.  Pharmacotherapies for Overeating and Obesity.

Authors:  S Yarnell; M Oscar-Berman; Nm Avena; K Blum; Ms Gold
Journal:  J Genet Syndr Gene Ther       Date:  2013-04-01

2.  Chronic pancreatitis and pancreatic pseudocyst with adult-onset type II citrullinemia.

Authors:  Toshihiko Kakiuchi; Aiko Nakayama; Takumi Akiyama; Muneaki Martsuo
Journal:  Clin J Gastroenterol       Date:  2019-06-29

3.  mRNA Therapy Improves Metabolic and Behavioral Abnormalities in a Murine Model of Citrin Deficiency.

Authors:  Jingsong Cao; Ding An; Mikel Galduroz; Jenny Zhuo; Shi Liang; Marianne Eybye; Andrea Frassetto; Eishi Kuroda; Aki Funahashi; Jordan Santana; Cosmin Mihai; Kerry E Benenato; E Sathyajith Kumarasinghe; Staci Sabnis; Timothy Salerno; Kimberly Coughlan; Edward J Miracco; Becca Levy; Gilles Besin; Joshua Schultz; Christine Lukacs; Lin Guey; Patrick Finn; Tatsuhiko Furukawa; Paloma H Giangrande; Takeyori Saheki; Paolo G V Martini
Journal:  Mol Ther       Date:  2019-04-23       Impact factor: 11.454

4.  Anesthetic experience of an adult male with citrullinemia type II: a case report.

Authors:  Jung Ju Choi; Hong Soon Kim; Kyung Cheon Lee; Youseok Shin; Youn Yi Jo
Journal:  BMC Anesthesiol       Date:  2016-10-11       Impact factor: 2.217

Review 5.  AGC2 (Citrin) Deficiency-From Recognition of the Disease till Construction of Therapeutic Procedures.

Authors:  Takeyori Saheki; Mitsuaki Moriyama; Aki Funahashi; Eishi Kuroda
Journal:  Biomolecules       Date:  2020-07-24

6.  Encephalopathy mimicking non-convulsive status Epilepticus.

Authors:  Ramachandiran Nandhagopal; Fathiya Al-Murshedi; Mujahid Al-Busaidi; Amna Al-Busaidi
Journal:  Neurosciences (Riyadh)       Date:  2018-01       Impact factor: 0.906

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.